Zhao P, Li X J, Zhang S F, Wang X S, Liu C Y
Chaoyang Centre for Disease Control and Prevention, Beijing, China.
J Int Med Res. 2012;40(2):436-45. doi: 10.1177/147323001204000205.
To determine risk factors associated with drug resistant tuberculosis (TB) in mainland China.
PubMed and Chinese BioMedical databases were searched. Cohort, case-control and cross-sectional studies providing effect estimates of risk factors for any-drug resistant or multidrug resistant (MDR) TB were included.
The meta-analysis included 16 studies. Any-drug resistant TB was significantly associated with poor quality directly observed treatment, shortcourse (DOTS) (odds ratio [OR] 2.65, 95% confidence interval [CI] 1.22, 5.79), long term illness > 1 year (OR 2.71, 95% CI 1.34, 5.48), poor treatment adherence (OR 2.00, 95% CI 1.17, 3.40), previous treatment (OR 4.54, 95% CI 2.71, 7.61) and age 40 - 60 years (OR 1.62, 95% CI 1.10, 2.38). MDR-TB was significantly associated with poor quality DOTS (OR 1.84, 95% CI 1.36, 2.49), poor treatment adherence (OR 4.39, 95% CI 2.97, 6.50), previous treatment (OR 3.83, 95% CI 2.12, 6.89) and poverty (OR 1.87, 95% CI 1.38, 2.52).
Previous treatment, poor quality DOTS, poor treatment adherence, long term illness, age 40 - 60 years and poverty are associated with a greater risk of drug resistant TB in mainland China.
确定中国大陆耐多药结核病(TB)的相关危险因素。
检索PubMed和中国生物医学数据库。纳入提供任何耐药或耐多药(MDR)结核病危险因素效应估计值的队列研究、病例对照研究和横断面研究。
荟萃分析纳入了16项研究。任何耐药结核病与直接观察下的短程治疗(DOTS)质量差显著相关(比值比[OR]2.65,95%置信区间[CI]1.22,5.79)、长期患病>1年(OR 2.71,95%CI 1.34,5.48)、治疗依从性差(OR 2.00,95%CI 1.17,3.40)、既往治疗史(OR 4.54,95%CI 2.71,7.61)以及年龄40 - 60岁(OR 1.62,95%CI 1.10,2.38)。耐多药结核病与DOTS质量差(OR 1.84,95%CI 1.36,2.49)、治疗依从性差(OR 4.39,95%CI 2.97,6.50)、既往治疗史(OR 3.83,95%CI 2.12,6.89)和贫困(OR 1.87,95%CI 1.38,2.52)显著相关。
既往治疗史、DOTS质量差、治疗依从性差、长期患病、年龄40 - 60岁和贫困与中国大陆耐多药结核病风险增加相关。